Shin-Ichi Harashima1, Akiko Nishimura2, Kaori Ikeda3, Yu Wang3, Yanyan Liu3, Nobuya Inagaki3. 1. Department of Diabetes, Endocrinology and Nutrition, Graduate School of Medicine, Kyoto University, Kyoto, Japan harasima@metab.kuhp.kyoto-u.ac.jp. 2. Department of Human Health Sciences, Graduate School of Medicine, Kyoto University, Kyoto, Japan. 3. Department of Diabetes, Endocrinology and Nutrition, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Abstract
BACKGROUND: The aim of this study was to compare glycemic control between SMBG-continued and -discontinued subjects with type 2 diabetes in the SMBG-OHA study. METHOD: Of the 96 subjects from the SMBG-OHA study, 59 were recruited for the 24-week, comparison follow-up study. The study outcomes were the differences in change in HbA1c levels at 24 weeks between the 2 groups, and change in SMBG frequency in SMBG-continued subjects. RESULTS: Although health insurance does not cover the cost of SMBG, 22.0% of subjects continued SMBG of their own will after the SMBG-OHA study was completed. HbA1c levels were maintained from 6.81 ± 0.55% to 6.64 ± 0.53% in SMBG-continued subjects. Conversely, HbA1c levels were increased from 7.18 ± 0.63% to 7.48 ± 0.84% in SMBG-discontinued subjects. HbA1c levels were significantly different by 0.83 ± 0.25% (95% CI: -1.33 to -0.36). The difference in change in HbA1c between the groups was -0.46% (95% CI: -0.78 to -0.15). SMBG frequency was decreased from 2.02 ± 1.06 to 1.53 ± 0.86 times a day. CONCLUSIONS: HbA1c levels were maintained in SMBG-continued subjects but increased in SMBG-discontinued subjects. The study implied that almost once daily SMBG is helpful to maintain glycemic control in non-insulin-treated type 2 diabetes.
BACKGROUND: The aim of this study was to compare glycemic control between SMBG-continued and -discontinued subjects with type 2 diabetes in the SMBG-OHA study. METHOD: Of the 96 subjects from the SMBG-OHA study, 59 were recruited for the 24-week, comparison follow-up study. The study outcomes were the differences in change in HbA1c levels at 24 weeks between the 2 groups, and change in SMBG frequency in SMBG-continued subjects. RESULTS: Although health insurance does not cover the cost of SMBG, 22.0% of subjects continued SMBG of their own will after the SMBG-OHA study was completed. HbA1c levels were maintained from 6.81 ± 0.55% to 6.64 ± 0.53% in SMBG-continued subjects. Conversely, HbA1c levels were increased from 7.18 ± 0.63% to 7.48 ± 0.84% in SMBG-discontinued subjects. HbA1c levels were significantly different by 0.83 ± 0.25% (95% CI: -1.33 to -0.36). The difference in change in HbA1c between the groups was -0.46% (95% CI: -0.78 to -0.15). SMBG frequency was decreased from 2.02 ± 1.06 to 1.53 ± 0.86 times a day. CONCLUSIONS: HbA1c levels were maintained in SMBG-continued subjects but increased in SMBG-discontinued subjects. The study implied that almost once daily SMBG is helpful to maintain glycemic control in non-insulin-treated type 2 diabetes.
Authors: M Franciosi; G Lucisano; F Pellegrini; A Cantarello; A Consoli; L Cucco; R Ghidelli; G Sartore; L Sciangula; A Nicolucci Journal: Diabet Med Date: 2011-07 Impact factor: 4.359
Authors: N Kleefstra; J Hortensius; S J J Logtenberg; R J Slingerland; K H Groenier; S T Houweling; R O B Gans; E van Ballegooie; H J G Bilo Journal: Neth J Med Date: 2010-08 Impact factor: 1.422
Authors: David C Klonoff; Lawrence Blonde; George Cembrowski; Antonio Roberto Chacra; Guillaume Charpentier; Stephen Colagiuri; George Dailey; Robert A Gabbay; Lutz Heinemann; David Kerr; Antonio Nicolucci; William Polonsky; Oliver Schnell; Robert Vigersky; Jean-François Yale Journal: J Diabetes Sci Technol Date: 2011-11-01
Authors: Uriëll L Malanda; Laura M C Welschen; Ingrid I Riphagen; Jacqueline M Dekker; Giel Nijpels; Sandra D M Bot Journal: Cochrane Database Syst Rev Date: 2012-01-18
Authors: Andrew Farmer; Alisha Wade; Elizabeth Goyder; Patricia Yudkin; David French; Anthea Craven; Rury Holman; Ann-Louise Kinmonth; Andrew Neil Journal: BMJ Date: 2007-06-25
Authors: William H Polonsky; Lawrence Fisher; Charles H Schikman; Deborah A Hinnen; Christopher G Parkin; Zhihong Jelsovsky; Bettina Petersen; Matthias Schweitzer; Robin S Wagner Journal: Diabetes Care Date: 2011-02 Impact factor: 19.112
Authors: Stéphanie Fabre; Pierre Clerson; Jean-Marie Launay; Jean-François Gautier; Tiphaine Vidal-Trecan; Jean-Pierre Riveline; Adam Platt; Anna Abrahamsson; Jeffrey N Miner; Glen Hughes; Pascal Richette; Thomas Bardin Journal: Arthritis Res Ther Date: 2018-05-02 Impact factor: 5.156